Bristol Myers Squibb (BMS) is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. They focus on therapeutic areas such as oncology, immunology, cardiovascular, hematology, and neuroscience. BMS combines the agility of biotech with the reach and resources of a major pharma company, striving to make a significant impact on patients' lives worldwide through scientific innovation and a commitment to quality and safety.
Serves as the central hub for global operations, research and development leadership, strategic planning, and corporate functions for Bristol Myers Squibb.
The Princeton Pike campus is a state-of-the-art facility featuring modern research laboratories, collaborative workspaces, and employee amenities. It's designed with sustainability in mind, often incorporating green spaces and energy-efficient technologies. The campus facilitates cutting-edge scientific research.
Bristol Myers Squibb fosters a work culture focused on innovation, collaboration, patient-centricity, and inclusion. Employees are encouraged to pursue scientific excellence and work cross-functionally to achieve breakthroughs in medicine. There is a strong emphasis on employee development, integrity, and passion for their mission.
The headquarters is critical as it drives the company's global strategy in tackling serious diseases. It's a key center for BMS's research efforts, global business operations, and corporate decision-making, impacting healthcare outcomes worldwide.
Bristol Myers Squibb maintains a significant global presence, supporting functions worldwide. These include extensive research and development operations, a network of advanced manufacturing and supply sites, and robust commercial operations (sales, marketing, market access). Additionally, medical affairs, regulatory affairs, and corporate support functions are distributed globally. The company has operations in North America, South America, Europe, Asia, and Australia, with offices and facilities designed to discover, develop, and deliver innovative medicines to patients in numerous countries around the world.
3401 Princeton Pike
Lawrenceville
New Jersey
USA
Address: Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH, UK
Key operational center for managing and expanding Bristol Myers Squibb's presence and product portfolio in the United Kingdom, contributing to European market strategies and patient access.
Address: 38 Jackson Rd, Devens, MA 01434, USA
Supports the global supply chain for Bristol Myers Squibb's biologic drugs, ensuring high-quality manufacturing capabilities in North America and contributing to both clinical trial supply and commercial product availability.
Address: Shinjuku I-Land Tower, 6-5-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo 163-1328, Japan
Drives Bristol Myers Squibb's commercial success and research initiatives in Japan, adapting global strategies to local healthcare needs, patient populations, and regulatory environments to deliver innovative medicines.
Address: Route de Perreux 1, 2017 Boudry, Switzerland
Ensures reliable production and supply of key medicines for European and other international markets, adhering to stringent quality and regulatory standards. Also involved in packaging and distribution.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Bristol' leadership includes:
Bristol has been backed by several prominent investors over the years, including:
The most significant executive change at Bristol Myers Squibb in the last 12 months (from mid-2023 to mid-2024) was the planned CEO transition. Christopher Boerner, Ph.D., succeeded Giovanni Caforio, M.D., as Chief Executive Officer in November 2023. Boerner was subsequently also appointed Chair of the Board in April 2024. Other executive team adjustments have been primarily internal promotions or role realignments rather than high-profile external hires or departures at the EVP level.
Discover the tools Bristol uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Bristol Myers Squibb primarily uses the 'first.last@bms.com' email format for its employees. This is a common and standard format for large corporations, facilitating professional communication.
first.last@bms.com
Format
jane.doe@bms.com
Example
92%
Success rate
BMS Press Release • May 22, 2024
The U.S. Food and Drug Administration (FDA) accepted Bristol Myers Squibb’s Biologics License Application (BLA) for subcutaneous nivolumab co-formulated with Halozyme’s rHuPH20 for priority review across several approved adult solid tumor indications for Opdivo (nivolumab) intravenous....more
BMS Press Release • April 25, 2024
Bristol Myers Squibb announced first quarter 2024 revenues of $11.9 billion, a 5% increase year-over-year, driven by strong performance of new products. The company also provided updates on its pipeline and strategic cost reduction initiatives....more
BMS Press Release • February 5, 2024
Bristol Myers Squibb announced the successful completion of its acquisition of RayzeBio, Inc., a clinical-stage radiopharmaceutical therapeutics company. This acquisition aims to strengthen BMS's oncology portfolio with innovative actinium-based radiotherapies....more
BMS Press Release • November 1, 2023
Christopher Boerner, Ph.D., officially assumed the role of Chief Executive Officer of Bristol Myers Squibb, succeeding Giovanni Caforio, M.D., who transitioned to Executive Chairman as part of a planned leadership succession announced earlier in the year....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Bristol, are just a search away.